When a COVID-19 Vaccine is available, most of the world will have access to it thanks to a unique platform for international cooperation called The COVAX Facility.
The COVAX Facility, which is also sometimes referred to as the COVAX Pillar, is essentially a platform for pooled investments in the development, manufacture and distribution of a COVID-19 vaccine. At time of recording, 172 countries have entered into an initial agreement with COVAX. This includes about 80 wealthier countries that would be able to purchase the vaccine on their own and 92 lower income countries which would not be able to self-finance the procurement of a vaccine.
The goal of the COVAX Facility is to provide 2 billion doses of a vaccine to cover 20% of the population of all participating countries by the end of 2021.
Of these organizations, GAVI–The Vaccine Alliance administers COVAX.
On the line with me today to explain how COVAX works is the Managing Director for Country Programs at GAVI Thabani Maphosa. We kick off discussing how the COVAX Facility was formed before having a broader conversation about how it works and why global cooperation on the development and distribution of a vaccine is a far more effective way to end this pandemic than countries going it alone.